A Study in Participants With Diabetic Peripheral Neuropathic Pain in China

Status Completed

Clinical Trial Summary

The purpose of this trial is to assess the efficacy of duloxetine 60 milligrams (mg) once daily (QD) compared with placebo, on the change in pain severity from baseline to 12 weeks as measured by the weekly mean of the daily pain scores recorded in the participant's diary in participants with diabetic peripheral neuropathic pain.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01179672
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 3
Start date	April 2011
Completion date	August 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04988321` - Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms	N/A
Completed	`NCT00385671` - An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain	Phase 4
Completed	`NCT00159679` - Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy	Phase 4
Completed	`NCT00141401` - Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.	Phase 3
Active, not recruiting	`NCT04469270` - Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00553475` - Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT00381719` - Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT00539175` - Treatment of Painful Diabetic Neuropathy With Photon Stimulation	N/A
Completed	`NCT00058968` - A Study for the Treatment of Painful Diabetic Neuropathy	Phase 3
Completed	`NCT05029297` - Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.	Phase 3
Completed	`NCT02215252` - A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)	Phase 2
Completed	`NCT00785577` - A Study for Treatment of Pain in Patients With Diabetic Neuropathy.	Phase 2
Completed	`NCT00858351` - Thermal Biofeedback for the Treatment of Diabetic Neuropathy	N/A
Completed	`NCT03047278` - Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.	Phase 4
Completed	`NCT01628627` - Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy	Phase 4
Completed	`NCT03315598` - Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain	N/A
Completed	`NCT01057693` - Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy	Phase 3
Completed	`NCT01564459` - Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)	Phase 2
Recruiting	`NCT01214590` - Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01089556` - A Study in Painful Diabetic Neuropathy	Phase 3